GSK-106623



Multicentre immune memory study in healthy children following a 3 dose primary vaccination with Prevenar or GSK Biologicals' pneumococcal conjugate vaccine via the administration of a single booster dose of Pneumovax 23
Pneumococcal Polysaccharide Conjugate Vaccine (Adsorbed)
106623
NCT00333450
Infections, Streptococcal
Phase 3
 
This is a follow up study to 105554. Follow on study 112807 was conducted.
March 2015